RSV Vaccines: ACIP Recommendations For Adults Younger Than Age 60 Await More Data

Delayed
ACIP recommendations on use of RSV vaccines in younger adults are delayed pending more data. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Geography